menu
    • menu

    Company profile for Zhejiang Jiuzhou Pharmaceutical

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INTERMEDIATES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is a medium-scale private enterprise, which focuses in the production of APIs. Our company grows out of Dongshan Chemical Factory which was founded in 1973. Under the direction of the President Mr. Hua Xuande, the staffs of Jiuzhou are fully obedience to the Jiuzhou spirit of “Unite, Progress, Strictness and Innovation". With the strict management for more than 30 years, Jiuzhou keep...
    Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is a medium-scale private enterprise, which focuses in the production of APIs. Our company grows out of Dongshan Chemical Factory which was founded in 1973. Under the direction of the President Mr. Hua Xuande, the staffs of Jiuzhou are fully obedience to the Jiuzhou spirit of “Unite, Progress, Strictness and Innovation". With the strict management for more than 30 years, Jiuzhou keeps growing. Today, Jiuzhou Pharmaceutical has turned into a large-scale cooperate limited pharmaceutical enterprise covering an area of 300,000 sq. m., about 2000 employees.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Jiuzhou PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    99 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.jiuzhoupharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 284

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaConnecting People, Mentalities & MarketsConnecting People, Mentalities & Markets

    Connecting People, Mentalities & Markets
    Connecting People, Mentalities & Markets

    reelConnecting People, Mentalities & Markets

    This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

    Impressions: 402

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    The first quarter (Q1) of 2025 witnessed an impressive surge in Drug Master File (DMF) submissions to the US Food and Drug Administration (FDA), signaling a robust expansion in pharmaceutical development activities, the looming threat of tariffs notwithstanding.A total of 339 Type II DMFs were submitted during this period, as opposed to 235 submissions in Q1 2024, marking an exceptional increase of 44.26 percent. PharmaCompass’ data suggests that this is a record high for any first quarter.Overall, 440 DMFs were submitted across all categories (Types II, III, IV, and V) during Q1 2025, compared to 353 in the same period last year — representing a 24.65 percent increase.India and China continued to dominate the DMF landscape. India led with 162 submissions in Q1 2025, posting a remarkable 51.4 percent increase over 107 submissions recorded in Q1 2024. China followed with 135 submissions, representing a 33.66 percent increase over the 101 filings in Q1 2024.Taiwan sprung a surprise as a distant third. It made 12 DMF submissions in Q1 2025, as opposed to just one in Q1 2024. Western countries like the US, Spain, Germany, and Italy have maintained relatively stable or declining submission rates. Only the Netherlands showed significant growth with four DMF submissions in Q1 2025, up from zero in Q1 2024. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available)Indian giants MSN, Aurobindo, Cipla, Dr Reddy’s lead record-breaking DMF surgeIndia lived up to its “pharmacy of the world” reputation with the highest DMF submissions. In fact, seven of the top eight companies in the DMF tally were headquartered in India. MSN Group, emerged as the unequivocal leader with 23 submissions in Q1 2025, as against 15 in Q1 2024. Aurobindo Pharma increased its DMF activity from seven submissions in Q1 2024 to 12 in Q1 2025. Alivus Life Sciences, formerly known as Glenmark, made a dramatic leap with eight submissions in Q1 2025, quadrupling its previous year’s count of just two. Cipla more than doubled its DMF submissions — from three in Q1 2024 to eight in Q1 2025.Dr. Reddy’s Laboratories, one of India’s largest generic drugmakers, filed seven DMF submissions. The company’s Q1 2025 DMF portfolio includes high-value molecules like deucravacitinib, finerenone, enzalutamide, niraparib tosylate monohydrate, tucatinib, and tizanidine hydrochloride.Dr. Reddy’s has also indicated that they are open to manufacturing in the US. Meanwhile, Hetero Drugs filed seven submissions while Lee Pharma recorded six in Q1 2025.Chinese manufacturer Jiangsu East-Mab Biomedical Technology also established a significant presence with six DMFs. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Semaglutide, finerenone see most DMF submissions; first-time filings surge 64%Semaglutide and finerenone emerged as the most documented molecules in Q1 2025, each garnering nine DMF submissions. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized diabetes management and weight loss treatment, continues to attract significant manufacturer interest. Similarly, finerenone, a non-steroidal drug used in treating chronic kidney disease in type 2 diabetes patients, has garnered attention from manufacturers.Carfilzomib, used in multiple myeloma treatment, secured the third position with five DMF submissions. Deucravacitinib, a novel drug approved for moderate to severe plaque psoriasis, followed with four DMF submissions.There were several molecules with three DMF submissions each. Among them were tapinarof, a novel drug for psoriasis, and tirzepatide, a GLP-1/GIP receptor agonist that has shown remarkable efficacy in diabetes and weight management. During the quarter, 23 molecules received their inaugural DMF submissions. This number has risen by 64 percent since Q1 2024, when only 14 drugs saw their first DMF filings.In Q1 2025, these 23 first-time molecules collectively garnered 30 DMF submissions, with deucravacitinib emerging as the clear leader. Indian companies Dr. Reddy’s Laboratories and Cipla filed DMFs for this plaque psoriasis treatment as did Spain’s Curia and PMC Global.The Q1 2025 roster of first-time DMF filings include retatrutide (another GLP-1 receptor agonist), sotagliflozin, setmelanotide acetate, daridorexant, nusinersen, zavegepant, belzutifan, elacestrant dihydrochloride, selumetinib sulfate, sotorasib, atogepant, omadacycline tosylate, osilodrostat phosphate, ensifentrine, landiolol hydrochloride, maralixibat chloride, maribavir, methyl olivetolate, diazoxide choline, sparsentan, thinnertide, and vismodegib. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Our viewGiven Trump’s rhetoric around tariffs on imported drugs, the record-breaking DMF submissions in Q1 2025 sent out a strong message that the global pharmaceutical industry is willing to take on the complex geopolitical situation with resilience and strategic foresight.On a different note, the rise in DMF filings also indicate increased workload for the FDA staff, as also more inspections by the agency. It seems like more ‘laid off’ FDA employees will be asked to return to work in the coming days.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 570

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions

    #PharmaFlow by PHARMACOMPASS
    15 May 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Jiuzhou Pharmaceutical Welcomes RayHua to Become a Group Member
    Jiuzhou Pharmaceutical Welcomes RayHua to Become a Group Member

    26 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jiuzhou-pharmaceutical-welcomes-rayhua-to-become-a-group-member-301808047.html

    PR NEWSWIRE
    26 Apr 2023
    Share Share
    Novartis' spinoff-headed Sandoz sells Chinese plant for $15.1M
    Novartis' spinoff-headed Sandoz sells Chinese plant for $15.1M

    29 Sep 2022

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/novartis-spinoff-headed-sandoz-sells-chinese-finished-drugs-plant-cdmo-jiuzhou-151m

    Angus Liu FIERCEPHARMA
    29 Sep 2022
    Share Share
    Novartis selling manufacturing site to Chinese drugmaker 
    Novartis selling manufacturing site to Chinese drugmaker 

    06 Sep 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/novartis-selling-manufacturing-site-to-chinese-drugmaker

    Eric Palmer FIERCE PHARMA
    06 Sep 2019
    Share Share
    Indian Govt impose anti-dump duty on bulk drug import of Gliclazide from China
    Indian Govt impose anti-dump duty on bulk drug import of Gliclazide from China

    17 Dec 2015

    // TWOFOUR INSIGHT

    http://twofourinsight.com/indian-government-protects-local-pharma-industry-imposes-anti-dumping-duty-on-bulk-imports-from-china-of-gliclazide/

    TWOFOUR INSIGHT
    17 Dec 2015
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Carbamazepine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Carbamazepine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14893

    Submission : 2000-05-19

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-221 - Rev 06

    Issue Date : 2019-02-05

    Type : Chemical

    Substance Number : 543

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10174

    Registrant's Address : Waisha Road 99, Jiaojiang, Taizhou City, Zhejiang, China 318000

    Initial Date of Registration : 2008-07-31

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65344-0028

    Start Marketing Date : 2019-07-16

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ketoprofen

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Ketoprofen

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 23636

    Submission : 2010-03-16

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2003-136 - Rev 08

    Issue Date : 2024-06-17

    Type : Chemical

    Substance Number : 922

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10157

    Registrant's Address : 18 Nan Yang San Road, Lin Hai City, Taizhou City Zhejiang Province

    Initial Date of Registration : 2013-08-14

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Sulfasalazine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Sulfasalazine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14724

    Submission : 2000-02-23

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-088 - Rev 02

    Issue Date : 2015-03-20

    Type : Chemical

    Substance Number : 863

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10016

    Registrant's Address : Waisha Road 99# Jiaojiang Taizhou City, Zhejiang China

    Initial Date of Registration : 2024-01-24

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Medica Korea Co., Ltd.

    Registration Date : 2012-02-24

    Registration Number : 20091224-105-F-46-02(1)

    Manufacturer Name : Zhejiang Jizhou Pharmaceutical Co., Ltd.

    Manufacturer Address : 99 waisha Road, Jiaojiang District, Taizhou City, Zhejiang province, 318000, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Gefitinib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Gefitinib

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-10-28

    Pay. Date : 2016-06-15

    DMF Number : 30518

    Submission : 2016-04-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2018-236 - Rev 01

    Issue Date : 2022-02-02

    Type : Chemical

    Substance Number : 2866

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65344-0029

    Start Marketing Date : 2023-12-29

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Gliclazide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Thoracic Society
    Not Confirmed
    arrow

    Gliclazide

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Thoracic Society
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-138 - Rev 01

    Issue Date : 2014-12-09

    Type : Chemical

    Substance Number : 1524

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10100

    Registrant's Address : Waisha Road 99# Jiaojiang Taizhou City, Zhejiang China

    Initial Date of Registration : 2015-04-09

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Imatinib Mesylate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Imatinib Mesylate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 23343

    Submission : 2009-11-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-235 - Rev 02

    Issue Date : 2024-09-26

    Type : Chemical

    Substance Number : 2736

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65344-0020

    Start Marketing Date : 2024-12-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Venlafaxine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Venlafaxine Hydrochloride

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-10-30

    Pay. Date : 2013-11-29

    DMF Number : 21195

    Submission : 2007-12-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-283 - Rev 00

    Issue Date : 2014-03-21

    Type : Chemical

    Substance Number : 2119

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65344-0017

    Start Marketing Date : 2011-08-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Meropenem

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Meropenem

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27686

    Submission : 2013-11-01

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 225MF10226

    Registrant's Address : No. 18, Nanyangsan Road, Linhai, Taizhou City, Zhejiang Province, P. R. China

    Initial Date of Registration : 2013-12-10

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Oxcarbazepine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Oxcarbazepine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20516

    Submission : 2007-05-03

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-230 - Rev 02

    Issue Date : 2024-12-12

    Type : Chemical

    Substance Number : 2577

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sulfadimethoxine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    STLE Annual Meeting
    Not Confirmed
    arrow

    Sulfadimethoxine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15646

    Submission : 2001-08-13

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65344-0011

    Start Marketing Date : 2024-12-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Zhejiang Jiuzhou Pharmaceutical Co Ltd and get a quotation

    Zhejiang Jiuzhou Pharmaceutical Co Ltd is a supplier offers 73 products (APIs, Excipients or Intermediates).

    Find a price of Carbamazepine bulk with CEP, JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Ketoprofen bulk with CEP, JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sulfasalazine bulk with CEP, JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Gefitinib bulk with DMF, CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Gliclazide bulk with CEP, JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Imatinib Mesylate bulk with DMF, CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Meropenem bulk with JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Oxcarbazepine bulk with CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of 10- Methoxy Iminostilbene bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Axitinib bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Bezafibrate bulk with CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Duloxetine Hydrochloride bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Gliclazide bulk with JDMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Molport-021-783-041 bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Oxcarbazepine bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sildenafil Citrate bulk with CEP offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sitagliptin Phosphate bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sulfadimethoxine bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sulfadimethoxine Sodium bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Venlafaxine Hydrochloride bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of LCA45 bulk with DMF offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of 10- Methoxy Iminostilbene bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Albendazole bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Atazanavir Sulfate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Atomoxetin Hydrochloride bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Clopidogrel bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Cyclohexanol bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Darunavir bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Erlotinib Hydrochloride bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of N-Methylparoxetine bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Nilotinib bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Paroxetine Hydrochloride bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Pregabalin bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Rivastigmine bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Rivastigmine Tartrate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Rufinamide bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sorafenib bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sulfasalazine bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Surecn2062622 bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Unii-269Gqp5C4X bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Venlafaxine bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of TRANS-(-)-PAROXOL bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Abacavir bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Acyclovir bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Amprolium bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Apixaban bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Atenolol bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Avibactam Sodium bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Baloxavir Marboxil bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of CAS 654671-77-9 bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Cilostazol bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Dapagliflozin bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Dexketoprofen Trometamol bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Edoxaban Tosylate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Ketoprofen Lysinate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Lacosamide bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Lenalidomide bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Loxoprofen Sodium bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Mirogabalin Besylate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Nirmatrelvir bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Rasagiline Mesylate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Ribociclib bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Rimegepant Sulfate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sacubitril Sodium bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sacubitril-Valsartan bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Semaglutide bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sitagliptin Hydrochloride bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Sulfadimethoxine bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Tenofovir Disoproxil Succinate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Vonoprazan Fumarate bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Find a price of Vortioxetine Hydrobromide bulk offered by Zhejiang Jiuzhou Pharmaceutical Co Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search